![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Paramyxoviridae: Respiratory Syncytial Virus
Disease: Acute upper and lower respiratory tract illness.
-
Chapter
Nosocomial Viral Infections
Disease: Viral infections and their associated illnesses acquired in the hospital or other health care facility.
-
Chapter
Strains of Respiratory Syncytial Virus: Implications for Vaccine Development
Within a few years after its discovery in 1957, respiratory syncytial virus (RSV) was shown to be the single most important pathogen of acute lower respiratory tract illness among infants and young children wo...
-
Chapter
Monoclonal Time-Resolved Fluoroimmunoassay: Sensitive Systems for the Rapid Diagnosis of Respiratory Virus Infections
The respiratory viruses afflict everyone, causing an average of three respiratory illnesses per person per year and millions of lost work days per year, at an enormous economic cost. There are over 200 viruses...
-
Chapter
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
Respiratory syncytial virus (RSV) causes a significant proportion of the global burden of respiratory disease. Here we summarize the conclusions of a series of chapters written by investigators describing and ...
-
Chapter
Clinical and Epidemiologic Features of Respiratory Syncytial Virus
Since its discovery in 1955, respiratory syncytial virus (RSV) has consistently been noted to be the single most important cause of lower respiratory tract illness in infants <1 year of age. RSV also causes re...